ERT and Bioclinica Close Merger


ERT has announced the close of its merger with Bioclinica. The transaction combines Bioclinica’s imaging knowledge, eClinical software, and drug safety solutions with ERT’s knowledge in eCOA, cardiac safety, respiratory and wearables.

Joe Eazor is the CEO of the merged company, and the management team will be composed of a combination of both ERT and Bioclinica executives.

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.